Frank Czerwiec

Frank Czerwiec, Chief Medical Officer, Sparrow Pharmaceuticals, has more than 35 years of experience in industry, academia, and public service, has been a medical researcher for over 30 years and maintains an active medical license with membership to the Endocrine Society and American Association of Clinical Endocrinologists. Motivated to find solutions for patients with serious unmet medical needs, Frank has worked in industry for the past 24 years, with roles at Goldfinch Bio, Otsuka Pharmaceuticals, and Merck before he joined Sparrow. Frank graduated from the University of Miami School of Medicine’s Combined MD/PhD program with a PhD in Biochemistry & Molecular Biology and continued post-doctoral training in the ABIM’s Internal Medicine Research Pathway Residency and NIH-NICHD/NIDDK’s Adult Endocrinology Fellowship.

Posts by Frank Czerwiec

MedCity Influencers, BioPharma

Realized Hope: Leveraging Our Modern Understanding of Human Biology To Fulfill the Decades-old Promise of a Miracle Drug

Seventy-four years ago, patients received hope for a medical miracle. Despite the disappointments which have accompanied that hope, steroids continue to play an important role in the treatment of debilitating symptoms of many autoimmune and other conditions. Now, equipped with decades of advances in our understanding of human biology, the time has come to innovate and execute on that promise.